UBS Global Asset Management Bloomberg US Liquid Corporates 1-5 Year UCITS ETF (UC82)

- Add to watchlist
- Create an alert
- This stock can be held in a




REPLICATION
SECURITIES LENDING
COUNTERPARTIES
Security | Weight |
---|---|
Amgen Inc | 1.25% |
Wells Fargo & Co | 1.16% |
Pfizer Investment Enterprises Pte Ltd | 1.15% |
Warnermedia Holdings Inc | 1.11% |
Pfizer Investment Enterprises Pte Ltd | 0.99% |
Morgan Stanley | 0.95% |
Wells Fargo & Company | 0.93% |
JPMorgan Chase & Co | 0.93% |
Wells Fargo & Company | 0.92% |
Bank Of America Corp | 0.90% |
ASSET SPLIT
Annual & interim reports
Before you invest, please make sure you read the documents below
OBJECTIVE
Index: | Barclays US Liquid Corporates 1-5 Year hedged to GBP Total Return |
---|---|
Aim: |
The UBS (Lux) Fund Solutions - Barclays US Liquid Corporates 1-5 Year UCITS ETF...
Read full aim for UBS Global Asset Management |
Leverage: | 100% |
Currency hedging: | Yes |
COSTS
Ongoing Charge (OCF/TER): | 0.19% |
---|---|
Management fee: | 0.19% |
Indicative spread: | 0.12% |
In certain cases, where no TER or OCF is shown, additional costs may apply. Please ensure you have read the Key Investor Information Document, Factsheet, Prospectus and any other relevant documentation prior to investing.
Company announcements
-
Net Asset Value(s)
20 May 2025 10:15
-
Net Asset Value(s)
19 May 2025 12:01
-
Net Asset Value(s)
16 May 2025 11:38
© Digital Look Ltd 1998-2025. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.